* Antolrx, Inc. announces Series A equity funding from
Pfizer, JDRF and Orion Equity Partners, LLC to develop targeted
Nanoparticle Tolerance Therapeutics
The post BRIEF-Antolrx announces series a equity funding from Pfizer, JDRF and Orion Equity Partners appeared first on NASDAQ.